Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016–2020

Ariana P Toepfer,Justin Z Amarin,Andrew J Spieker,Laura S Stewart,Mary Allen Staat,Elizabeth P Schlaudecker,Geoffrey A Weinberg,Peter G Szilagyi,Janet A Englund,Eileen J Klein,Marian G Michaels,John V Williams,Rangaraj Selvarangan,Christopher J Harrison,Joana Y Lively,Pedro A Piedra,Vasanthi Avadhanula,Brian Rha,James Chappell,Meredith McMorrow,Heidi Moline,Natasha B Halasa

DOI: https://doi.org/10.1093/cid/ciae085

IF: 20.999

2024-02-19

Clinical Infectious Diseases

Abstract:Background Respiratory syncytial virus (RSV) is a leading cause of acute respiratory illnesses (ARI) in children. RSV can be broadly categorized into two major subtypes (A and B). RSV subtypes have been known to co-circulate with variability in different regions of the world. Clinical associations with viral subtype have been studied among children with conflicting findings such that no conclusive relationships between RSV subtype and severity have been established. Methods During 2016–2020, children <5 years old were enrolled in prospective surveillance in the emergency department (ED) or inpatient (IP) settings from seven U.S. pediatric medical centers. Surveillance data collection included parent/guardian interviews, chart reviews, and collection of mid-turbinate nasal +/- throat swabs for RSV (RSV-A, RSV-B, and Untyped) by reverse transcription polymerase chain reaction (RT-PCR). Results Among 6398 RSV-positive children <5 years old, 3424 (54%) had subtype RSV-A infections, 2602 (41%) had subtype RSV-B infections, and 272 (5%) were not typed, inconclusive, or mixed infections. In both adjusted and unadjusted analyses, RSV-A-positive children were more likely to be hospitalized, as well as when restricted to <1 year. By season, RSV-A and RSV-B co-circulated in varying levels, with one subtype dominating proportionally. Conclusion Findings indicate that RSV-A and RSV-B may only be marginally clinically distinguishable but both subtypes are associated with medically attended illness in children <5 years old. Furthermore, circulation of RSV subtypes varies substantially each year, seasonally and geographically. With introduction of new RSV prevention products, this highlights the importance of continued monitoring of RSV-A and RSV-B subtypes.

immunology,infectious diseases,microbiology

What problem does this paper attempt to address?

The paper attempts to address the issue of the seasonal, clinical characteristics, and outcomes of different subtypes (A and B) of respiratory syncytial virus (RSV) in children. Specifically, the study aims to describe the prevalence of different RSV subtypes (A and B) in children in the United States and analyze the relationship between these subtypes and clinical severity. By analyzing data from seven pediatric medical centers in the United States from 2016 to 2020, the study hopes to reveal the following points:

1. **Seasonal variation of RSV subtypes**: Investigate the distribution of different subtypes across different seasons and regions.
2. **Differences in clinical characteristics**: Compare the differences in age, gender, underlying diseases, and other aspects between children infected with RSV-A and RSV-B subtypes.
3. **Clinical severity**: Assess the relationship between different subtype infections and severity indicators such as hospitalization rates, intensive care, and intubation.

Through these analyses, the study hopes to provide important information for public health policymakers regarding RSV prevention strategies, especially in terms of monitoring and response measures following the introduction of new vaccines and preventive products.